Effect of enzyme replacement therapy with agalsidase alfa on left ventricular mass in patients with Anderson Fabry disease: two-year results from FOS- the Fabry Outcome Survey | Charles Explorer

Effect of enzyme replacement therapy with agalsidase alfa on left ventricular mass in patients with Anderson Fabry disease: two-year results from FOS- the Fabry Outcome Survey

Publikace

Abstrakt

Fabry disease

Osoby